Key Metrics of Revvity Inc.
Revenue$2.8B▼ 16.9% YoYFY 2023
Operating income$301M▼ 59.5% YoY
Net profit$693M▲ 21.8% YoY
Shareholders' equity$7.9B
Market cap$17.6BRVTY · $157.36
Competitors10identified
About Revvity Inc.
Sectors
Company details
- Website
- revvity.com
- Listed
- NYSE: RVTY
Operational Areas of Revvity Inc.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameRevvity Inc.
TickerRVTY
ExchangeNYSE
CountryUnited States
SEC CIK0000031791
Listed since—
IndustryBiotechnology: Laboratory Analytical Instruments
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://revvity.com
US market & SEC filings
RVTY · NYSE · SEC CIK 0000031791
Last price · 25 Oct 2026
$157.36
+0.48%
Market cap$17.6B
P/E28.4On FY 2023 diluted EPS
Volume1,779,849
SectorIndustrialsBiotechnology: Laboratory Analytical Instruments
Country · IPOUnited States
RVTY share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeWaltham
GSTIN—
Email—
Websitehttp://revvity.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Revvity Inc.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Similar companies
K
Kbk Biotech Private LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
Anthem Biosciences (India)Pharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
International Biotech Park LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bharat Immunologicals And Biologicals Corporation LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Beam TherapeuticsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BioMarin PharmaceuticalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bio-Rad LaboratoriesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.